Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by HistoSonics

News headline image
HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors
From HistoSonics
Via Business Wire
News headline image
HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion
From HistoSonics
Via Business Wire
News headline image
HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors
From HistoSonics
Via Business Wire
News headline image
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)
From HistoSonics
Via Business Wire
News headline image
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
From HistoSonics
Via Business Wire
News headline image
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
From HistoSonics
Via Business Wire
News headline image
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members
From HistoSonics
Via Business Wire
News headline image
HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
From HistoSonics
Via Business Wire
News headline image
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
From HistoSonics
Via Business Wire
News headline image
HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation
From HistoSonics
Via Business Wire
News headline image
HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan
From HistoSonics
Via Business Wire
News headline image
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
From HistoSonics
Via Business Wire
News headline image
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
From HistoSonics
Via Business Wire
News headline image
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
From HistoSonics
Via Business Wire
News headline image
HistoSonics® Awarded Exclusive Contract with Veterans Affairs for Tumor Destroying Histotripsy Systems
From HistoSonics
Via Business Wire
News headline image
HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
From HistoSonics
Via Business Wire
News headline image
HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong
From HistoSonics
Via Business Wire
News headline image
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform
From HistoSonics
Via Business Wire
News headline image
HistoSonics Awarded Key Position in UK’s Novel Innovation Program
From HistoSonics
Via Business Wire
News headline image
World’s First Patients Treated With Novel Edison® Histotripsy System
From HistoSonics
Via Business Wire
News headline image
HistoSonics Notches Significant Reimbursement Wins
From HistoSonics
Via Business Wire
News headline image
FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
From HistoSonics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.